Completed Studies
Completed Research Initiatives.
Over the years, Mbale Clinical Research Institute (MCRI) has successfully completed numerous studies that have contributed significantly to public health knowledge and practice. These studies have addressed a range of critical issues, from improving nutritional assessments to enhancing disease prevention strategies in low-resource settings. Each completed project has provided valuable data and insights, helping shape health policies and informing future research directions. MCRI’s work has not only advanced scientific understanding but has also had a meaningful impact on community health by providing evidence-based recommendations that support sustainable development and improved health outcomes.
NUTIP
Nutritional Intervention in Pneumonia Trial (NuTiP)
NuTiP is a multicentre randomised controlled trial evaluating whether short-term nutritional support improves recovery among children hospitalised with severe pneumonia and hypoxia. The study planned to enrol 840 children aged 6 months to 12 years across hospitals in Uganda and Kenya. Participants received either daily ready-to-use therapeutic food for 56 days alongside their usual diet or usual care alone. The study assessed nutritional recovery, mortality, hospital readmission and longer-term health outcomes over six months.
PAC
Primaquine in African Children Study (PAC)
PAC was a multicentre clinical trial evaluating the safety of adding a single low dose of primaquine to standard malaria treatment in African children, including those with glucose-6-phosphate dehydrogenase deficiency. Conducted in Uganda and the Democratic Republic of the Congo, the study enrolled 1,137 children with uncomplicated falciparum malaria. Primaquine was well tolerated, with a safety profile comparable to placebo. The findings support wider use of single low-dose primaquine to reduce malaria transmission in Africa.
TABS PKPD
Pharmacokinetics and Pharmacodynamics of Azithromycin in Severe Malaria Bacterial Co-infection in African Children
TABS PKPD is clinical trial involving the investigation of Pharmacokinetics and Pharmacodynamics of Azithromycin in severe malaria and Bacterial co-infection in African Children. The key objectives include: to establish the dose for oral dispersible Azithromycin as an antimicrobial treatment for children with severe malaria, and investigate the antibiotics that can be targeted to those at great risk of Bacterial co-infection using clinical criteria alone or in combination with rapid diagnostic biomarker tests.
FLACSAM
First-Line Antimicrobials in Children with Complicated Severe Acute Malnutrition.
The FLACSAM Study was a multicentre clinical trial evaluating improved first-line antibiotic treatment for children admitted with complicated severe acute malnutrition. Conducted in Kenya and Uganda, including Mbale Regional Referral Hospital, it compared ceftriaxone with standard antibiotic treatment and assessed the additional value of metronidazole. The study examined mortality, nutritional recovery, antimicrobial resistance, drug dosing and treatment costs, generating evidence to improve treatment guidelines for vulnerable malnourished children in African hospitals.
MIMBLE II
Modifying Intestinal Integrity and Microbiome in Malnutrition with Legume-Based Feeds.
The MIMBLE Study investigated whether locally relevant legume-enriched nutritional feeds could improve recovery in Ugandan children hospitalised with severe acute malnutrition. Conducted at Mbale Regional Referral Hospital, the research compared modified feeds containing fermentable carbohydrates with standard WHO therapeutic milk feeds. It assessed survival, nutritional recovery, diarrhoea, intestinal health and changes in the gut microbiome. The findings showed that legume-based feeds produced nutritional outcomes comparable to standard feeds and supported further development of gut-focused treatments for severe malnutrition.
TRACT
Transfusion and Treatment of Severe Anaemia in African Children.
The TRACT Study was a large multicentre clinical trial that evaluated blood-transfusion and post-discharge treatment strategies for African children hospitalised with severe anaemia. Conducted in Uganda and Malawi, including at Mbale Regional Referral Hospital, the study enrolled 3,199 children. It examined when transfusion should begin, the appropriate volume of blood, and whether nutritional supplementation or cotrimoxazole could improve recovery. Its findings have provided important evidence for safer and more effective management of severe childhood anaemia.
FEAST
Fluid Expansion as Supportive Therapy Trial (FEAST)
FEAST was a multicentre randomised controlled trial investigating fluid-resuscitation strategies in 3,170 critically ill African children with severe infections and impaired circulation. Conducted at hospitals in Uganda, Kenya and Tanzania, it compared rapid fluid boluses using saline or albumin with maintenance fluids alone. The trial found that fluid boluses increased mortality compared with maintenance fluids. These unexpected findings significantly influenced understanding of paediatric emergency care and fluid management in resource-limited African hospitals.
COCS
Coronavirus Disease 2019 Open Cohort Study (COCS)
The Coronavirus Disease 2019 Open Cohort Study was designed to strengthen understanding of COVID-19 case definitions, epidemiology, clinical presentation and outcomes. It combined a voluntary global online cohort with retrospective and prospective hospital surveillance at Mbale and Soroti Regional Referral Hospitals. The project examined COVID-19 risk factors, co-infections, hospitalisation and mortality, and assessed how the pandemic affected other major diseases. Its findings were intended to support evidence-based surveillance, public-health communication, clinical research and future outbreak preparedness.
COAST
Gastroenteritis is a very common cause of diarrhoea and vomiting. It is most likely to be caused by a bacterial or viral stomach infection and is particularly common in young children. This trial study was conducted at MCRI.
GTS
Development of Geospatio-Temporal Surveillance and Characterisation of Malaria in the Changing Climatic Conditions in Eastern Uganda Study.
The GTS-MACS Study investigates how changing temperature, rainfall and humidity affect malaria transmission across Eastern, Northern and Northeastern Uganda. Led by Busitema University and Mbale Clinical Research Institute, the study combines geospatial surveillance, parasite-clearance monitoring and molecular analysis of antimalarial-resistance markers. Its findings have identified geographical differences in malaria patterns and emerging resistance-associated mutations, providing evidence to strengthen surveillance, guide treatment policies and support targeted malaria-control interventions in Uganda.
GASTROSAM
Gastroenteritis Rehydration of Children with Severe Acute Malnutrition (GASTROSAM): A Phase II Randomised Controlled Trial.
GASTROSAM was a multicountry clinical trial investigating safer and more effective ways to rehydrate children with severe acute malnutrition and diarrhoea. Conducted in Uganda, Kenya, Niger and Nigeria, the study compared oral and intravenous rehydration strategies in children aged 6 months to 12 years. Its findings showed that carefully monitored intravenous fluids and standard WHO oral rehydration solution can be used safely, providing important evidence for simplifying international treatment guidelines.
GASTRO
Gastroenteritis Aggressive Versus Slow Treatment for Rehydration (GASTRO): A Phase II Rehydration Trial for Severe Dehydration—WHO Plan C Versus Slow Rehydration.
The GASTRO Study evaluated two intravenous rehydration strategies for children admitted with severe dehydration caused by acute gastroenteritis. Conducted in Uganda and Kenya, the trial compared the standard WHO Plan C regimen with a simpler, slower eight-hour infusion. Both approaches produced similar clinical outcomes, with no evidence that slower rehydration increased serious adverse events. The findings supported further research into safe, practical rehydration protocols for critically ill African children.